Product Information
CARBIDOPA-LEVODOPA 25-100 TAB is a generic product labeled by TruPharma LLC, priced at $0.0766 per EA under NDC 52817039150. Its NADAC has been published 156 times since Aug 30, 2023.
FDA first approved this application on Sep 21, 2022. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
25; 100 mg/1; mg/1
Manufacturer
TruPharma LLCNDC
52817039150
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
CARBIDOPA; LEVODOPAApproval Type
Generic (ANDA)
FDA Application
ANDA216505FDA Approved
9/21/2022
TE Code
AB
On Market Since
9/21/2022
Pharmacological Classes
Price Statistics
The NADAC for CARBIDOPA-LEVODOPA 25-100 TAB has been published 156 times since Aug 30, 2023, and over the history we have for it it has declined 21.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0766 per EA |
|---|---|
| All-time high | $0.1014 (Jan 10, 2024) |
| All-time low | $0.0617 (Nov 20, 2024) |
| 52-week high | $0.0876 |
| 52-week low | $0.0719 |
| Median price | $0.0862 |
| Average price | $0.0842 |
| Largest weekly change | -30.7% (Nov 20, 2024) |
| Weeks tracked | 156 |
| Tracking since | Aug 30, 2023 |
Generic Alternatives
The matcher finds 6 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 6% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of CARBIDOPA-LEVODOPA 25-100 TAB?
The current National Average Drug Acquisition Cost (NADAC) for CARBIDOPA-LEVODOPA 25-100 TAB, manufactured by TruPharma LLC, is $0.0766 per EA (NDC 52817039150), effective Aug 19, 2026.
How has the price of CARBIDOPA-LEVODOPA 25-100 TAB changed over time?
Over the history we have for it, the NADAC for CARBIDOPA-LEVODOPA 25-100 TAB has declined 21.7%. It has been tracked across 156 weekly CMS publications since Aug 30, 2023.
What are the highest and lowest recorded NADAC prices for CARBIDOPA-LEVODOPA 25-100 TAB?
Since Aug 30, 2023, the NADAC for CARBIDOPA-LEVODOPA 25-100 TAB has ranged from a low of $0.0617 (Nov 20, 2024) to a high of $0.1014 (Jan 10, 2024), with a median of $0.0862 per EA.
Are there cheaper alternatives to CARBIDOPA-LEVODOPA 25-100 TAB?
Yes. 6 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, CARBIDOPA-LEVODOPA 25-100 TAB, is $0.0724 per EA — about 6% below CARBIDOPA-LEVODOPA 25-100 TAB.
Who manufactures CARBIDOPA-LEVODOPA 25-100 TAB?
CARBIDOPA-LEVODOPA 25-100 TAB (NDC 52817039150) is labeled by TruPharma LLC, and CMS classifies it as a generic product.